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S ummarx 
Drugs known to inhibit phenylethanolamine-N-methyltransferase (EC 
2.1.1.28), the final enzyme in the epinephrine synthetic pathway 
were administered to rats and their effects on pituitary-arenal 
function studied. 2,3-Dichloro-a-methylbenzylamine (DCMB) produced 
dose-related increases in plasma corticosterone in basal and 
stressed rats. Evidence for the central nature of this tonic 
inhibitory effect of epinephrine was its continued presence in 
adrenal demedullated rats. 2-Chloro-3-trifluoromethyl-~-benzyl- 
amine (CTFMB) administration elevated plasma corticosterone and 
this effect was highly correlated to the decrease in hypothalamic 
epinephrine concentration in both sham operated and adrenal 
demedullated rats. These findings argue for tonic epinergic 
inhibition of pituitary-adrenal function. 
Introduction 
The mammalian central nervous system is known to possess cells containing 
phenylethanolamine-N-methyltransferase (PNMT; EC 2.1.1.28), the enzyme that 
converts norepinephrine to epinephrine, as well as epinephrine i tsel f  (1,2,3, 
4,5). Several possible functions for epinergic neurons in physiology and 
behavior have been suggested, including vasomotor control, sympathetic regu- 
lation, stress regulation (6,7) and neuroendocrine regulation of growth 
hormone release (8). Adrenergic neurons may possess more general neuroendo- 
crine properties, however. One or more catecholamines normally inhibits the 
secretion of adrenocorticotropic hormone in rats, dogs, and primates (9). 
The direct injection of norepinephrine or epinephrine into the third ventri- 
cle of pentobarbital-anesthetized dogs produced an inhibition of corticoid 
output in response to surgical stress (10). The existence of pharmacological 
*The term "epinergic neuron" is defined as a neuron containing the enzymes 
in the catecholamine pathway, including phenylethanolamine-N-methyltrans- 
ferase as well as epinephrine i tsel f .  The term epinergic is used to avoid 
the ambiguity of the term adrenergic neuron which has alternatively been 
defined as a neuron containing either catecholamines ( i .e . ,  norepinephrine 
or epinephrine) or a neuron containing epinephrine. 
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agents which are cen t ra l l y  active inh ib i to rs  of PNMT allows invest igat ion of 
the role of epinergic neurons in p i tu i tary-adrenal  function. Indeed, experi-  
ments with the PNMT inh ib i to r  SKF 64139 have been suggested but no resul ts 
have as yet been published ( i0 ) .  However, experiments with th is  par t i cu la r  
PNMT inh ib i to r  may be d i f f i c u l t  to in terpret  since SKF 64139 is a potent 
monoamine oxidase inh ib i to r  as well as possessing ~2-receptor-blocking 
properties ( i i ) .  The PNMT inh ib i to rs  2,3-dichloro-a-methylbenzylamine (DCMB) 
and 2-chloro-3- t r i f luoro-methyl - : -benzylamine (CTFMB) do not show MAO 
inh ib i to r  properties (12) and to our knowledge are not e2 antagonists. 
These two compounds were therefore used to invest igate the possible contr ibu- 
t ions of PNMT containing neurons to normal p i tu i tary-adrenal  regulat ion. 
Plasma cort icosterone, and in some experiments hypothalamic catecholamines, 
were examined fol lowing PNMT inh ib i t i on .  
Materials and Methods 
Adult male Sprage-Dawley rats (Charles River Farms), each 70 days at the 
s tar t  of test ing were group-housed with food (Teklad 4.0 percent fa t  rodent 
d iet  S-0836) and tap water avai lab le,  and normal 12 h/12 h l igh t ing  ( l igh ts  
on 0800-2000h). 
Experiments began between 0800 and i000 h. Rats were b r i e f l y  removed and 
injected in t raper i tonea l l y  with 0.9 percent sodium chloride vehicle or 
2,3-dichloro-:-methylbenzylamine (DCMB) or 2-ch loro-3- t r i f luoromethy l -e-  
benzylamine (CTFMB). Additonal experiments employed subgroups of adrenal 
demedullated or surgical control ra ts ,  prepared 3 weeks pr ior  to the exper i -  
ments by standard surgical procedures (13), and rats i nd i v idua l l y  exposed to 
95 dB of white noise for  i h pr ior  to sacr i f i ce  according to procedures 
developed within our laboratory (14). 
Al l  rats were sacr i f iced by decapitation 4 hours post in ject ion.  Time 
between f i na l  cage removal and sacr i f i ce  was less than 30 sec. Trunk blood 
was col lected in heparinized tubes and subsequently centrifuged at 2400 RPM 
for 30 min. Plasma was removed and frozen at -40 ° un t i l  assayed by competi- 
t i ve  protein binding assay by the method of Murphy (15). Corticosterone was 
employed as the assay standard and determinations were made in t r i p l i c a t e .  
Within assay, coef f ic ients  of variance were less than 5 percent. 
Brains were removed and immediately frozen on dry ice and stored in small 
containers at -40°C unt i l  dissected. Brains were allowed to p a r t i a l l y  thaw 
on a ch i l led  glass plate rest ing on a bed of ice and hypothalami were removed 
and placed in 1.5 ml polypropylene tubes and stored on dry ice unt i l  assayed. 
The concentrations of hypothalamic epinephrine, norepinephrine, dopamine, and 
dihydroxyphenylacetic acid (DOPAC) were measured using ion pair ing reverse 
phase HPLC with electrochemical detection as previously described (16). 
S ta t i s t i ca l  comparisons u t i l i zed  univar iate analysis of variance (17). 
Results 
Both drugs produced a dose related increase in plasma cort icosterone. At 
the higher dose, a 3-4-fold increase in c i rcu la t ing  steroid above baseline 
levels was observed. A highly s ign i f i can t  inverse corre lat ion was found 
between hypothalamic epinephrine and plasma corticosterone concentrations. 
This ef fect  was seen in both surgical control and adrenal demedullated rats.  
The hypothalamic concentrations of norepinephrine, dopamine, and DOPAC were 
not related to plasma corticosterone concentrations in e i ther  group. 
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Figure 1 displays the effects of DCMB (F=8.9; df=2,27; p < .001) and 
CTFMB (Part B) on plasma corticosterone. I t  may be seen that significant 
increases occur in both surgical control and adrenal demedullated rats 
(F=2.9; df=5,28; p < .003). CTFMB produced a dose related decrease in 
hypothalamic epinephrine in control (F=6.1; df=2,14; p < .05) and adrenal 
demedullated rats (F=5.0; df=2,13; p < .05). Hypothalamic norepinephrine, 
dopamine and DOPAC were not affected by CTFMB. These results are presented 
in Table I .  The relationship between hypothalamic epinephrine and plasma 
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Figure 1. 




DCMB or CTFMB was administered IP to cont ro l  or adrenal demedullated ra ts  
four  hours p r i o r  to blood c o l l e c t i o n .  The PNMT i n h i b i t o r s  produced a dose 
re la ted  r i se  in plasma co r t i cos te rone .  
To further examine the influence of PNMT inhibit ion upon corticosterone, 
rats were examined in a factorial study involving noise stress and an 
intermediate level of DCMB. In Table 2 i t  may be seen that both DCMB and 
stress increase plasma corticosterone and their combined effect was an 
additive one. Thus, two PNMT inhibitors increased corticosterone. A 
signif icant increase also occurred in the absence of the adrenal medulla, 
and i t  occurred in a manner that did not appear to depend upon stress. 
Discussion 
The present findings suggest that epinergic neurons are involved in the 
tonic inhibitory control of plasma corticosterone in the rat. These findings 
appear to depend upon central epinephrine, adrenal demedullated rats showed 
increased corticosterone after PNMT inhibit ion. The lack of effect of CTFMB, 
at the doses tested, on hypothalamic norepinephrine, dopamine, and DOPAC is 
evidence for the speci f ic i ty  of this compound in inhibit ing epinephrine 
synthesis. We have reported that the PNMT inhibitor SKF 64139 is a potent 
in vivo MAD inhibitor (11), however CTFMB and DCMB do not appear to have this 
property (12). 
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Figure 2. 
Various doses of CTFMB were administered to sham operated (a) or adrenal 
demedullated (b) rats. In both groups the concentration of hypothalamic 
epinephrine was inversely related to plasma corticosterone concentration. 
TABLE 1. 
HYPOTHALAMIC CATECHOLS X * SEM 
ng/g tissue 
SHAM EPINEPHRINE NOREPINEPHRINE 
0 mg/kg CTFMB (6) 48.6 * 6.9 2432 ± 169 
15 mg/kg CTFMB (6) 33.8 * 3.2 2374 * 110 
30 mg/kg CTFMB (5) 25.3 ± 6.2 1957 * 226 
F = 6.10 2.71 
df = 2,14 2,14 
p < .05 NS 
ADMX EPINEPHRINE NOREPINEPHRINE 
0 mg/kg CTFMB (6) 42.1 * 3.1 2282 * 130 
15 mg/kg CTFMB (5) 37.6 * 4.4 2654 * 314 
30 mg/kg CTFMB (5) 25.5 * 5.4 2263 * 235 
F = 4.96 1.12 
df = 2,13 2,13 
p < .05 NS 
DOPAMINE 
389 * 39 
392 * 25 





462 * 29 
490 * 57 





159 * 18 
120 * 12 





209 ~ 11 
179 * 08 
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TABLE 2. 
Mean Corticosterone (+ SEM) Following Stress 
and Drug Treatment in the Rat 
Stress 
Drug: 
Basal Acute Stress 
NACL 2.1 * 0.5 35.3 * 2.7 a 
DCMB 3.7 ± 0.4 a 39.5 * 2.4 a,b 
20 mg/kg 
a) p < .05 in comparison with saline control (~ test for independent samples) 
b) p < .05 in comparison with DCMB control (~ test for independent samples). 
The argument could be raised that CTFMB and DCMB produce an i r r i t a t i o n  
which leads to an increased corticosterone concentration due to a stress 
response. This is very un l i ke ly  for several reasons: I )  stress produces a 
r ise in hypothalamic DOPAC levels (18), th is  response was not found af ter  
PNMT inh ib i t i on ;  2) stress may in teract  with PNMT inh ib i t i on  to decrease the 
concentration of hypothalamic norepinephrine (19), th is  did not occur in the 
present experiment; 3) the " i r r i t a n t "  e f fect  would need to be c losely 
correlated to the a b i l i t y  of CTFMB to lower hypothalamic epinephrine as 
hypothalamic epinephrine concentrations were shown to be inversely related 
to plasma corticosterone concentrations; 4) the elevation in plasma 
cort icosterone by DCMB was s t i l l  present when rats were exposed to a 95 dB 
white noise stress, a procedure which also elevates corticosterone levels.  
On balance the p o s s i b i l i t y  that these f indings are due to a nonspecific 
i r r i t a n t  e f fect  is un l i ke ly .  
Since elevated cor t icostero ids,  and ACTH, are of physiological and 
psychiat r ic  s igni f icance,  the present f indings may shed l i gh t  upon the 
regulat ion of normal cort icosterone release and also upon disease states 
characterized by elevated steroid levels .  This f i na l  point of course assumes 
some degree of commonality in the endocrine system of rats and other species. 
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